(e.g. yourname@email.com)

Forgot Password?

    Defense Visual Information Distribution Service Logo

    Congressionally Directed Medical Research Programs      

     

      SHOW UNIT INFO

    Current Personnel:

    Geoffrey Heinzl
    Sarah Keasey
    Naomi Rendina

    Content Online:

    Video: 
    0
    Audio: 
    0
    25
    Images: 
    0
    0
    0

    Recent News Stories

    CDMRP Funds Research to Accelerate Treatments for...
    02.27.2026 | Courtesy Story
    In fiscal year 2026, the CDMRP received congressional appropriations to address rare cancers and several rare diseases and conditions with potential to impact Service Members during or after service, or their Family members, impacting military readiness. Through creation of registries and repositories to increase access to small patient populations and few samples, innovative clinical trial designs that reduce participation burden, and...

    CDMRP Funds Research to Detect Military-Related...
    01.13.2026 | Courtesy Story
    The Toxic Exposures Research Program supports research to improve detection of military-relevant toxic exposures and diagnosis of exposure-related illnesses and health outcomes for Service Members, Veterans and their Families.

    CDMRP-Funded Research Supports Suicide Prevention...
    12.16.2025 | Courtesy Story
    The Congressionally Directed Medical Research Programs fund research for interventions to predict, prevent and treat Warfighters who exhibit early indicators of suicidal behaviors or suicidal ideation. By addressing service-specific factors impacting the mental health and well-being of Service Members, CDMRP-funded research preserves military readiness and the strength, stability and effectiveness of the U.S. Armed Forces.

    CDMRP Advances AI-Based Metastatic Cancer Detection...
    12.02.2025 | Courtesy Story
    Together, CDMRP-funded researchers and their partners at the Department of Veterans Affairs advance research using AI to detect cancer spread and predict recurrence, improving survival for those who served our country and everyone impacted by metastatic disease.

    CDMRP Advances Breast Cancer Care for Military...
    12.01.2025 | Courtesy Story
    The Breast Cancer Research Program plays a leading role in the fight against breast cancer by funding innovative research that will bring an end to the disease. Female breast cancer accounted for the highest cancer incidence rate for the ten leading cancers among active-duty members of the military between 2018 and 2022. Innovative research funded by the BCRP contributes to high-impact advances in clinical practice and treatment used within...

    CDMRP-Funded Research Supports Early Detection of...
    09.30.2025 | Courtesy Story
    Since fiscal year 2011, the Alzheimer’s Research Program received $213 million in congressional appropriations, including $15 million in fiscal year 2025, to support research to transform diagnosis and care for people living with Alzheimer’s disease and related dementias. Research funded by the AZRP supports identification of new biomarkers and risk factors for Alzheimer’s disease and related dementias, including risks associated with...

    CDMRP Accelerates Advancements in Cancer Screening...
    09.24.2025 | Courtesy Story
    In fiscal year 2025, the Congressionally Directed Medical Research Programs received $407.5 million in congressional funding to address various cancers with relevance to military health and potential impact to mission readiness. By focusing on patient-identified needs, the CDMRP cancer programs aim to lower the overall impact of cancer on Service Members, Veterans, Families and the Nation.

    CDMRP Supports Critical Developments in ALS, a...
    08.11.2025 | Courtesy Story
    Since fiscal year 2007, the Amyotrophic Lateral Sclerosis Research Program received $309.4 million in congressional appropriations, including $40 million in fiscal year 2025, to support research to find new treatments and cures for ALS. Research funded by the ALSRP led to experimental treatments, new biomarkers, and devices advancing through clinical trials or in development with industry partners.
    More CDMRP News